Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Burger

Showing results (221-230 of 342) with videos related to

Pageof 35
Sort By:
Urologic Oncology|September 12, 2017
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinomaMichael Rink, Oliver Engel, Georgios Gakis, et al.
Caspian Journal of Internal Medicine|August 1, 2019
Awareness and perception of multidrug-resistant organisms and antimicrobial therapy among internists vs. surgeons of different specialties: Results from the German MR2 SurveyPhilipp J Spachmann, Matthias May, Malte W Vetterlein, et al.
Urologia Internationalis|November 6, 2023
Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE StudyDanijel Sikic, Christian Fiebig, Bernd Wullich, et al.
Cancers|February 24, 2024
Urine-Based Biomarker Test Uromonitor<sup>®</sup> in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer-A Systematic Review and Meta-Analysis of Diagnostic Test PerformanceAnton P Kravchuk, Ingmar Wolff, Christian Gilfrich, et al.
European Urology|September 5, 2017
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 UpdateMorgan Rouprêt, Marko Babjuk, Eva Compérat, et al.
Diagnostics (Basel, Switzerland)|January 28, 2026
Diagnostic Performance and Clinical Utility of the Uromonitor<sup>®</sup> Molecular Urine Assay for Urothelial Carcinoma of the Bladder: A Systematic Review and Diagnostic Accuracy Meta-AnalysisJulio Ruben Rodas Garzaro, Anton Kravchuk, Maximilian Burger, et al.
Clinical Genitourinary Cancer|October 29, 2015
Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaMichael Rink, Armin Soave, Roland Dahlem, et al.
World Journal of Urology|June 2, 2011
No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional studyMaximilian Burger, Shahrokh F Shariat, Hans-Martin Fritsche, et al.
Urologia Internationalis|July 29, 2025
Acute kidney injury causes chronic kidney disease progression after partial nephrectomy: A retrospective study identifying patients at riskSebastian Kälble, Simon Udo Engelmann, Maximilian Haas, et al.
Urologia Internationalis|December 20, 2016
ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situJohannes Breyer, Wolfgang Otto, Ralph M Wirtz, et al.
Pageof 35

Showing results (221-230 of 342) with videos related to

Sort By:
Pageof 35
Urologic Oncology|September 12, 2017
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinomaMichael Rink, Oliver Engel, Georgios Gakis, et al.
Caspian Journal of Internal Medicine|August 1, 2019
Awareness and perception of multidrug-resistant organisms and antimicrobial therapy among internists vs. surgeons of different specialties: Results from the German MR2 SurveyPhilipp J Spachmann, Matthias May, Malte W Vetterlein, et al.
Urologia Internationalis|November 6, 2023
Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE StudyDanijel Sikic, Christian Fiebig, Bernd Wullich, et al.
Cancers|February 24, 2024
Urine-Based Biomarker Test Uromonitor<sup>®</sup> in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer-A Systematic Review and Meta-Analysis of Diagnostic Test PerformanceAnton P Kravchuk, Ingmar Wolff, Christian Gilfrich, et al.
European Urology|September 5, 2017
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 UpdateMorgan Rouprêt, Marko Babjuk, Eva Compérat, et al.
Diagnostics (Basel, Switzerland)|January 28, 2026
Diagnostic Performance and Clinical Utility of the Uromonitor<sup>®</sup> Molecular Urine Assay for Urothelial Carcinoma of the Bladder: A Systematic Review and Diagnostic Accuracy Meta-AnalysisJulio Ruben Rodas Garzaro, Anton Kravchuk, Maximilian Burger, et al.
Clinical Genitourinary Cancer|October 29, 2015
Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaMichael Rink, Armin Soave, Roland Dahlem, et al.
World Journal of Urology|June 2, 2011
No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional studyMaximilian Burger, Shahrokh F Shariat, Hans-Martin Fritsche, et al.
Urologia Internationalis|July 29, 2025
Acute kidney injury causes chronic kidney disease progression after partial nephrectomy: A retrospective study identifying patients at riskSebastian Kälble, Simon Udo Engelmann, Maximilian Haas, et al.
Urologia Internationalis|December 20, 2016
ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situJohannes Breyer, Wolfgang Otto, Ralph M Wirtz, et al.
Pageof 35